These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30954310)

  • 1. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 2. Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice.
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Feb; 110():95-104. PubMed ID: 30466007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].
    Cao L; Wang S; Zhang L; Li J
    Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro" [Biomed. Pharmacother. 109 (2019) 1016-1023].
    Zhang N; An X; Lang P; Wang F; Xie Y
    Biomed Pharmacother; 2020 Oct; 130():110720. PubMed ID: 34321161
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice." [Biomed. Pharmacother. 150 (2022) 112936].
    Zhang D; Ji P; Sun R; Zhou H; Huang L; Kong L; Li W; Li W
    Biomed Pharmacother; 2024 Jan; 170():115965. PubMed ID: 38040625
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis" [Biomed. Pharmacother. 92 (2017) 962-971].
    Mou Z; Huang Q; Chu SF; Zhang MJ; Hu JF; Nai-Hong C; Zhang JT
    Biomed Pharmacother; 2024 Aug; 177():117034. PubMed ID: 38926051
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells" [Biomed. Pharmacother. 90 (2017) 906-913].
    Soni N; Jyoti K; Jain UK; Katyal A; Chandra R; Madan J
    Biomed Pharmacother; 2018 Sep; 105():1360. PubMed ID: 29929878
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
    Xu R; Peng Y; Wang M; Fan L; Li X
    J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression" [Biomed. Pharmacother. 115 (2019) 108869].
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2020 Feb; 122():109789. PubMed ID: 31864836
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis" [Biomed. Pharmacother. 106 (2018) 813-820].
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2019 Mar; 111():1509. PubMed ID: 30413297
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms" [Biomed. Pharmacother. 115 (2019) 108881].
    Wen J; Wang J; Li P; Wang R; Wang J; Zhou X; Zhang L; Li H; Wei S; Cai H; Zhao Y
    Biomed Pharmacother; 2019 Jul; 115():108936. PubMed ID: 31101386
    [No Abstract]   [Full Text] [Related]  

  • 12. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
    Zhan S; Guo W; Shao Q; Fan X; Li Z; Cheng Y
    J Ethnopharmacol; 2014 Mar; 152(2):333-9. PubMed ID: 24462784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Cellular landscaping of cisplatin resistance in cervical cancer" Biomed. Pharmacother. 153(2022) 113345.
    Bhattacharjee R; Dey T; Kumar L; Kar S; Sarkar R; Ghorai M; Malik S; Jha NK; Vellingiri B; Kesari KK; Pérez de la Lastra JM; Dey A
    Biomed Pharmacother; 2024 Aug; 177():117097. PubMed ID: 38964956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of ginsenoside Rb1 in ameliorating insulin resistance and ectopic fat deposition in obese mice induced by high fat diet].
    Shang WB; Yu XZ; Wang GQ; Zhao J
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4119-23. PubMed ID: 24791501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
    Joh EH; Lee IA; Jung IH; Kim DH
    Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.
    Kang A; Zhang S; Zhu D; Dong Y; Shan J; Xie T; Wen H; Di L
    Chem Biol Interact; 2016 Oct; 258():187-96. PubMed ID: 27613481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rb1 Attenuates Isoflurane/surgery-induced Cognitive Dysfunction via Inhibiting Neuroinflammation and Oxidative Stress.
    Miao HH; Zhang Y; Ding GN; Hong FX; Dong P; Tian M
    Biomed Environ Sci; 2017 May; 30(5):363-372. PubMed ID: 28549492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice" [Biomed. Pharmacother. 118 (2019) 109206].
    Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
    Biomed Pharmacother; 2019 Oct; 118():109290. PubMed ID: 31471002
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Comparative study of therapeutic response to baclofen vs tolperisone in spasticity" [Biomed. Pharmacother. 87 (2017) 628-635].
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Aug; 92():1140. PubMed ID: 28623068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on PK-PD characteristics of ginsenoside Rg1 and Rb1, in rats with myocardial ischemia following intravenous administration of shengmai injection].
    Zhan SY; Shao Q; Li Z; Wang Y; Fan XH
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1300-5. PubMed ID: 25011272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.